Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021
Descripción del Articulo
Objective: To determine antimicrobial resistance in secondary peritonitis in patients with chronic kidney disease (CKD) undergoing peritoneal dialysis at the Almanzor Aguinaga- Asenjo Hospital EsSalud-Lambayeque between 2019 and 2021. Material and methods: Descriptive and retrospective study, on 135...
| Autores: | , , |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2025 |
| Institución: | Colegio Médico del Perú |
| Repositorio: | Acta Médica Peruana |
| Lenguaje: | español |
| OAI Identifier: | oai:amp.cmp.org.pe:article/2835 |
| Enlace del recurso: | https://amp.cmp.org.pe/index.php/AMP/article/view/2835 |
| Nivel de acceso: | acceso abierto |
| Materia: | Peritoneal Dialysis Peritonitis Microbial Sensitivity Test Anti-Bacterial Agents Drug Resistance Microbial Diálisis peritoneal Pruebas de Sensibilidad Microbiana Antibacterianos Farmacorresistencia Microbiana |
| id |
REVCMP_7fdf25ce26616382409f489ba2f147eb |
|---|---|
| oai_identifier_str |
oai:amp.cmp.org.pe:article/2835 |
| network_acronym_str |
REVCMP |
| network_name_str |
Acta Médica Peruana |
| repository_id_str |
. |
| spelling |
Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021Resistencia antibiótica de microorganismos enperitonitis secundaria a diálisis peritoneal en elHospital Almanzor Aguinaga Asenjo, EsSalud-Lambayeque 2019 – 2021Díaz-Muñoz, Juan C.Serrano-Morales, Luis M.Pecsén-Monteza, José E.Díaz-Muñoz, Juan C.Serrano-Morales, Luis M.Pecsén-Monteza, José E.Peritoneal DialysisPeritonitisMicrobial Sensitivity TestAnti-Bacterial AgentsDrug Resistance MicrobialDiálisis peritonealPeritonitisPruebas de Sensibilidad MicrobianaAntibacterianosFarmacorresistencia MicrobianaObjective: To determine antimicrobial resistance in secondary peritonitis in patients with chronic kidney disease (CKD) undergoing peritoneal dialysis at the Almanzor Aguinaga- Asenjo Hospital EsSalud-Lambayeque between 2019 and 2021. Material and methods: Descriptive and retrospective study, on 135 peritonitis episodes according to case records. Forty-seven episodes from 33 patients met inclusion criteria, and 88 episodes were excluded due to lack of reporting or bacterial isolation. Data was analyzed using the R studio 4.1.3 statistical package for Windows, expressing values as percentage and frequency. Results: More than half of patients (57.6%) were male, and median age was 54 years; 47.2% were diabetic and had high blood pressure. Oxacillin, vancomycin, gentamicin, and ciprofloxacin resistant coagulase-negative Staphylococcus were isolated (34%); cefazolin, ampicillin/sulbactam, and cotrimoxazole resistant Pseudomonas aeruginosa (21.3%); cotrimoxazole, ciprofloxacin, ceftriaxone, and cefepime resistant Escherichia coli (19.2%); and oxacillin and vancomycin resistant Staphylococcus aureus (10.6%) were also isolated. Conclusions: The most common antimicrobial-resistant microorganism is coagulase-negative Staphylococcus, found to be resistant to oxacillin, vancomycin, gentamicin, and ciprofloxacin.Objetivo: determinar la resistencia antibiótico-microbiana en peritonitis secundaria de pacientes con ERC en diálisis peritoneal del Hospital Almanzor Aguinaga Asenjo, EsSalud-Lambayeque, entre 2019 y 2021. Materiales y métodos: estudio descriptivo y retrospectivo, en 135 episodios de peritonitis según registro de casos; 47 episodios de 33 pacientes cumplieron criterios de inclusión y 88 episodios fueron excluidos por falta de reporte o aislamiento bacteriano. Los datos se analizaron con el paquete estadístico R Studio 4.1.3 para Windows, expresándolos en porcentajes y frecuencias. Resultados: el 57,6% fueron varones y la mediana de edad fue de 54 años; el 47,2% eran diabéticos e hipertensos; se aisló Staphylococcus coagulasa-negativo (34%), resistente a oxacilina, vancomicina, gentamicina y ciprofloxacino; Pseudomona aeruginosa (21,3%), resistente a cefazolina, ampicilina/sulbactam y cotrimoxazol; Escherichia coli (19,2%), resistentes a cotrimoxazol, ciprofloxacino, ceftriaxona y cefepime; y Staphylococcus aureus (10,6%), resistente a oxacilina y vancomicina. Conclusiones: el microorganismo más frecuente fue Staphylococcus coagulasa-negativo, resistente a oxacilina, vancomicina, gentamicina y ciprofloxacino.Colegio Médico del Perú2025-03-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/xmlhttps://amp.cmp.org.pe/index.php/AMP/article/view/283510.35663/amp.2025.421.2835ACTA MEDICA PERUANA; Vol. 42 No. 1 (2025): January - March; 55-60ACTA MEDICA PERUANA; Vol. 42 Núm. 1 (2025): Enero – Marzo; 55-601728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/2835/1957https://amp.cmp.org.pe/index.php/AMP/article/view/2835/1983Copyright (c) 2025 ACTA MEDICA PERUANAhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:amp.cmp.org.pe:article/28352025-11-08T19:15:30Z |
| dc.title.none.fl_str_mv |
Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021 Resistencia antibiótica de microorganismos enperitonitis secundaria a diálisis peritoneal en elHospital Almanzor Aguinaga Asenjo, EsSalud-Lambayeque 2019 – 2021 |
| title |
Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021 |
| spellingShingle |
Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021 Díaz-Muñoz, Juan C. Peritoneal Dialysis Peritonitis Microbial Sensitivity Test Anti-Bacterial Agents Drug Resistance Microbial Diálisis peritoneal Peritonitis Pruebas de Sensibilidad Microbiana Antibacterianos Farmacorresistencia Microbiana |
| title_short |
Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021 |
| title_full |
Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021 |
| title_fullStr |
Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021 |
| title_full_unstemmed |
Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021 |
| title_sort |
Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021 |
| dc.creator.none.fl_str_mv |
Díaz-Muñoz, Juan C. Serrano-Morales, Luis M. Pecsén-Monteza, José E. Díaz-Muñoz, Juan C. Serrano-Morales, Luis M. Pecsén-Monteza, José E. |
| author |
Díaz-Muñoz, Juan C. |
| author_facet |
Díaz-Muñoz, Juan C. Serrano-Morales, Luis M. Pecsén-Monteza, José E. |
| author_role |
author |
| author2 |
Serrano-Morales, Luis M. Pecsén-Monteza, José E. |
| author2_role |
author author |
| dc.subject.none.fl_str_mv |
Peritoneal Dialysis Peritonitis Microbial Sensitivity Test Anti-Bacterial Agents Drug Resistance Microbial Diálisis peritoneal Peritonitis Pruebas de Sensibilidad Microbiana Antibacterianos Farmacorresistencia Microbiana |
| topic |
Peritoneal Dialysis Peritonitis Microbial Sensitivity Test Anti-Bacterial Agents Drug Resistance Microbial Diálisis peritoneal Peritonitis Pruebas de Sensibilidad Microbiana Antibacterianos Farmacorresistencia Microbiana |
| description |
Objective: To determine antimicrobial resistance in secondary peritonitis in patients with chronic kidney disease (CKD) undergoing peritoneal dialysis at the Almanzor Aguinaga- Asenjo Hospital EsSalud-Lambayeque between 2019 and 2021. Material and methods: Descriptive and retrospective study, on 135 peritonitis episodes according to case records. Forty-seven episodes from 33 patients met inclusion criteria, and 88 episodes were excluded due to lack of reporting or bacterial isolation. Data was analyzed using the R studio 4.1.3 statistical package for Windows, expressing values as percentage and frequency. Results: More than half of patients (57.6%) were male, and median age was 54 years; 47.2% were diabetic and had high blood pressure. Oxacillin, vancomycin, gentamicin, and ciprofloxacin resistant coagulase-negative Staphylococcus were isolated (34%); cefazolin, ampicillin/sulbactam, and cotrimoxazole resistant Pseudomonas aeruginosa (21.3%); cotrimoxazole, ciprofloxacin, ceftriaxone, and cefepime resistant Escherichia coli (19.2%); and oxacillin and vancomycin resistant Staphylococcus aureus (10.6%) were also isolated. Conclusions: The most common antimicrobial-resistant microorganism is coagulase-negative Staphylococcus, found to be resistant to oxacillin, vancomycin, gentamicin, and ciprofloxacin. |
| publishDate |
2025 |
| dc.date.none.fl_str_mv |
2025-03-31 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://amp.cmp.org.pe/index.php/AMP/article/view/2835 10.35663/amp.2025.421.2835 |
| url |
https://amp.cmp.org.pe/index.php/AMP/article/view/2835 |
| identifier_str_mv |
10.35663/amp.2025.421.2835 |
| dc.language.none.fl_str_mv |
spa |
| language |
spa |
| dc.relation.none.fl_str_mv |
https://amp.cmp.org.pe/index.php/AMP/article/view/2835/1957 https://amp.cmp.org.pe/index.php/AMP/article/view/2835/1983 |
| dc.rights.none.fl_str_mv |
Copyright (c) 2025 ACTA MEDICA PERUANA https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
Copyright (c) 2025 ACTA MEDICA PERUANA https://creativecommons.org/licenses/by/4.0 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf text/xml |
| dc.publisher.none.fl_str_mv |
Colegio Médico del Perú |
| publisher.none.fl_str_mv |
Colegio Médico del Perú |
| dc.source.none.fl_str_mv |
ACTA MEDICA PERUANA; Vol. 42 No. 1 (2025): January - March; 55-60 ACTA MEDICA PERUANA; Vol. 42 Núm. 1 (2025): Enero – Marzo; 55-60 1728-5917 1018-8800 reponame:Acta Médica Peruana instname:Colegio Médico del Perú instacron:CMP |
| instname_str |
Colegio Médico del Perú |
| instacron_str |
CMP |
| institution |
CMP |
| reponame_str |
Acta Médica Peruana |
| collection |
Acta Médica Peruana |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1849686670238023680 |
| score |
13.4082 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).